Evidence map›Paper›PMID 36750897›Full record

Trial reportBMC health services research2023

"Augmenting the referral pathway for retinal services among diabetic patients at Reiyukai Eiko Masunaga Eye Hospital, Nepal: a non-randomized, pre-post intervention study".

Ruchi Shrestha, Prerana Singh, Parami Dhakwa, Shailaja Tetali, Tripura Batchu, Pragati Shrestha Thapa, Varun Agiwal, Hira Pant

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC health services research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04829084 (Augmenting the Referral Pathway to Improve the Uptake of Retinal Services Among Diabetic Patients at Reiyukai Eiko Masunaga Eye Hospital, Nepal, a Non-randomized Pre-post Intervention Study), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04829084 nacompletednot on this map

Augmenting the Referral Pathway to Improve the Uptake of Retinal Services Among Diabetic Patients at Reiyukai Eiko Masunaga Eye Hospital, Nepal, a Non-randomized Pre-post Intervention Study

TypeinterventionalSponsorSeva FoundationRan2021 to 2021Enrolled19ConditionsDiabetic RetinopathyArmsPre-post educational intervention
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ruchi ShresthaReiyukai Eiko Masunaga Eye Hospital, Banepa, Kavre, Nepal. drruchishrestha@gmail.com.
Prerana SinghReiyukai Eiko Masunaga Eye Hospital, Banepa, Kavre, Nepal.
Parami DhakwaSEVA Foundation, Kathmandu, Nepal.
Shailaja TetaliIndian Institute of Public Health, Hyderabad, India.
Tripura BatchuIndian Institute of Public Health, Hyderabad, India.
Pragati Shrestha ThapaReiyukai Eiko Masunaga Eye Hospital, Banepa, Kavre, Nepal.
Varun AgiwalIndian Institute of Public Health, Hyderabad, India.
Hira PantIndian Institute of Public Health, Hyderabad, India.
Indian Institute of Public Health Gandhinagar · INTilganga Institute of Ophthalmology · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic Retinopathy (DR) is an important public health issue in Nepal. Despite the availability of retinal services, people may not access them because of the lack of knowledge about DR and poor referral systems. DR screening uptake was low at Reiyukai Eiko Masunaga Eye Hospital(REMEH) since retina services were started. Scheer Memorial Hospital is a multispeciality hospital near to REMEH. It has no eye department but has been running a regular diabetic clinic. This was a site for referring diabetic patients for DR screening. Improving DR awareness among general physicians has the potential to address these challenges.

methodsThe aim of our study was to investigate the effectiveness of providing health education to selected health personnel and establish a referral pathway on the attendance of diabetic patients for retinal screening at REMEH. This was a non-randomized, pre-post intervention study design. Total of three health education sessions were provided to the health care professionals of Scheer on diabetic retinopathy using Power Point presentations, posters, pamphlets and videos. The study period was 16 months (2020 June -2021 September) and divided into 8 months pre-intervention(baseline data collection) and 8 months post intervention period. The proportional increase in number of diabetes attendance pre and post intervention was calculated by Z test. The change in knowledge of health care personnels pre and post intervention was scored and evaluated through a questionnaire and calculated by paired- t test. Data was analyzed using Excel and Epi Info 7.The Protocol was published on August 21, 2021, in JMIR Publications.

resultsThe proportional increase in number of referrals of diabetes attendance post intervention increased from 50 to 95% and was statistically significant (p < 0.001, 95% CI: 0.214-0.688). The mean score of knowledge gained by physicians on DR awareness was more at post intervention (8.8 ± 1.32) than pre intervention (6.4 ± 1.51). It was statistically significant (p < 0.001).

conclusionThis study shows that a well-planned health education intervention changes the knowledge in physicians about DR. There is an increase in the number of referrals and attendance of patients for DR screening with the change in knowledge and referral mechanism.

trial registrationClinical Trials.gov NCT04829084; https://clinicaltrials.gov/ct2/show/NCT04829084 :02/04/2021.

Indexed as

Diabetes MellitusDiabetic RetinopathyGeneral PractitionersHospitalsHumansMass ScreeningNepalReferral and ConsultationRetinaDiabetesDiabetic retinopathyHealth educationScreening

Identifiers

PMID36750897
PMCPMC9905012
OpenAlexW4319460630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.